Company / Revenue
AGIOS PHARMACEUTICALS, INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$54.0M
FY2025
5-year range
$0 / $54.0M
FY2021-FY2025
Trend
+48.0%
vs FY2024
Sector context
#119 of 155
Health Care
What the data says
AGIOS PHARMACEUTICALS, INC.'s revenue of $54M is lower than 77% of companies in the Health Care sector (FY2025). Revenue has increased for 3 consecutive years, from $0 in FY2022 to $54M in FY2025.
Based on SEC 10-K filings.
$54M in FY2025 with a 5-year CAGR of -10.6%.
Improved from $27M to $54M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -10.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 155This company $54.0M Sector average $4.5B
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.6%, indicating a declining trend.
- In FY2025, revenue increased 48.0% year-over-year.
- Ranks #119 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.0M | +48.0% |
| FY2024 | $36.5M | +36.1% |
| FY2023 | $26.8M | - |
| FY2022 | $0 | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $94.4M | -20.0% |
| FY2019 | $117.9M | +68.7% |
| FY2018 | $69.9M | +565.1% |
| FY2017 | $10.5M | -85.0% |
| FY2016 | $69.9M | +104.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026